ShineyoMedical

ShineyoMedical, established in May 2020, is located in Shanghai's Zhangjiang Hi-Tech Core Park, known as the "China Medicine Valley." The company owns a 2,000-square-meter R&D office and a production base with a Class 10,000 cleanroom that meets the national standards for the production of Class III medical devices. With over 20 patents, ShineyoMedical is a leading innovative medical device enterprise in China that has dual platforms in electrophysiology and peripheral intervention. Relying on its self-developed technology platforms for active medical devices, vascular interventional catheters, and biomaterials, the company has also strategically positioned itself in blue ocean markets: the research and development of innovative medical devices for cardiac electrophysiology and peripheral intervention. Currently, the company’s leading atrial fibrillation pulsed field ablation system and venous closure system have both completed preclinical validation and entered the clinical registration research phase.